3 stocks that analysts say could be worth more than Tesla in 10 years

Tesla has recently regained the attention of investors. After plummeting 43% at the beginning of the year, the automotive giant's stock has recovered since April, increasing in value by more than 130%. With a market capitalization of more than $1 trillion, Tesla remains one of the most important players in the market. Yet analysts predict that several other companies could surpass Tesla within a decade, thanks to steady growth or exceptional potential.

Here are three stocks worth mentioning 👇

Berkshire Hathaway: certainty and stability

Berkshire Hathaway $BRK-B $BRK-A already has a market capitalization nearly on par with Tesla - approximately $1.01 trillion. This investment conglomerate led by Warren Buffett benefits from its diversified structure that includes insurance, energy and railroads.

Analysts say Berkshire's stability and long-term investments could outweigh Tesla's momentum. While Tesla $TSLA relies on innovations in electric mobility and automation, Berkshire is in a strong position due to its conservative investments and substantial cash reserve, which is around $325 billion. That cash could be key in a market correction, when Buffett could acquire attractive assets at bargain prices.

Broadcom: powered by artificial intelligence

Broadcom $AVGO, a semiconductor manufacturer, is another company that analysts consider a candidate to outperform Tesla. With a market capitalization of around $810 billion, Broadcom has a good starting point, but its real potential lies in the rapid development of artificial intelligence (AI)-related technologies.

Broadcom's products, such as Ethernet networking devices and proprietary AI accelerators, are in growing demand. The acquisition of VMware is expected to deliver further significant gains. Analysts also point to an attractive price-performance ratio compared to other AI stocks.

If demand for AI technologies continues to grow - especially in the case of breakthroughs in autonomous agents or general artificial intelligence - Broadcom could benefit from a massive expansion of these markets.

Eli Lilly: A bet on healthcare

Pharmaceutical company Eli Lilly $LLY may seem a less likely candidate given its current market capitalization of $692 billion. Still, the drugmaker has a chance thanks to its extraordinary successes in obesity and diabetes treatments.

The Mounjaro and Zepbound drugs brought in over $11 billion in sales during the first three quarters of 2024. Analysts say revenue from Mounjaro could reach $34 billion by 2029, more than what Lilly earned overall last year.

Of course, there are risks, such as if some products in the development pipeline fail clinical trials. However, analysts remain optimistic that Eli Lilly can continue to grow its portfolio and take advantage of the growing global demand for medical innovations.

Disclaimer: There is plenty of inspiration to be found on Bulios, but stock selection and portfolio construction is up to you, so always conduct thorough self-analysis.

Source: Yahoo Finance, TheMotleyFool.